Something’s off with Midjourney’s pivot to body scanners

The buried issue here is regulatory reality: medical imaging devices require FDA 510(k) clearance or PMA approval, a process that typically runs two to five years and demands clinical trial data that a generative AI image company has no obvious track record producing. The 'rivals MRI' framing does a lot of work without any supporting evidence.

This is largely disconnected from recent activity in our archive. It belongs to a broader pattern, visible across the AI industry but not yet covered here, of software-native AI companies announcing hardware ambitions before demonstrating the operational infrastructure to execute them. The medical device space is a particularly unforgiving test case because the feedback loop is not user engagement metrics but regulatory approval and clinical outcomes. Midjourney's core competency is training generative image models on aesthetic data, which is a genuinely different discipline from building validated diagnostic hardware.

Watch whether Midjourney names an FDA regulatory strategy or a manufacturing partner within the next six months. Without either, this stays in concept territory regardless of how compelling the prototype imaging looks.